Sutro Biopharma, Inc. (STRO): Capital Expenditures

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Capital Expenditures is for the year ended 2018-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$1.56M
Year ended 2018-12-31
$4.39M2016-12-31: $4.39M2017-12-31: $3.32M2018-12-31: $1.56M$1.56M
2016-12-31 Capital Expenditures (USD) 2018-12-31
Period endedCapital ExpendituresChange YoYSource filing
2018-12-31$1.56M-53.0%2019-04-01, From 2018-01-01
2017-12-31$3.32M-24.5%2019-04-01, From 2017-01-01
2016-12-31$4.39Mn/a2019-04-01, From 2016-01-01